- IN₹228.74bn
- IN₹202.57bn
- IN₹22.81bn
- 98
- 15
- 97
- 84
Annual balance sheet for Pfizer, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11,025 | 16,204 | 18,464 | 20,341 | 27,885 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,247 | 2,481 | 1,930 | 2,399 | 2,147 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 19,247 | 23,614 | 24,933 | 27,378 | 35,129 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,951 | 2,201 | 1,855 | 1,514 | 1,795 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 32,659 | 39,005 | 40,007 | 42,288 | 49,111 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,743 | 8,529 | 6,574 | 5,466 | 5,695 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,729 | 10,361 | 7,934 | 6,332 | 6,937 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 23,930 | 28,644 | 32,073 | 35,955 | 42,174 |
| Total Liabilities & Shareholders' Equity | 32,659 | 39,005 | 40,007 | 42,288 | 49,111 |
| Total Common Shares Outstanding |